MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 911-916

  Shin, Kyeong Cheol ^a   Lee, Kwan Ho ^a   Lee, Chae Hun ^a   Shin, Im Hee ^b   Suh, Hun Suk ^b   Jeon, Chang Ho ^b  

^a Yeungnam University College of Medicine   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

Lung cancer; Melanoma antigen gene A3; Melanoma antigen gene RT PCR; Methylation; p16; Sputum

Indexed keywords

MELANOMA ANTIGEN; PROTEIN P16;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA EXTRACTION; FEMALE; GENE; GENE EXPRESSION; GENE LOCATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG DISEASE; MAGE A1-A6 GENE; MAGE A3 GENE; MAJOR CLINICAL STUDY; MALE; METHYLATION; P16 GENE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPUTUM ANALYSIS; TUMOR BIOPSY;

AGED; ANTIGENS, NEOPLASM; BIOPSY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; DNA METHYLATION; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MELANOMA-SPECIFIC ANTIGENS; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPUTUM;

EID: 84863082048     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1566     Document Type: Article

References (25)

1. Park JW, Kwon TK, Kim IH, et al: A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods 266: 79-86, 2002. (Pubitemid 34804674)
2. Jheon S, Hyun DS, Lee SC, et al: Lung cancer detection by a RT-nested PCR using MAGE A1-6 common primers. Lung Cancer 43: 29-37, 2004. (Pubitemid 38096289)
3. Jang SJ, Soria JC, Wang L, et al: Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 61: 7959-7963, 2001. (Pubitemid 33049388)
4. van der Bruggen P, Traversari C, Chomez P, et al: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991. (Pubitemid 21917508)
5. De Plaen E, Arden K, Traversari C, et al: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369, 1994. (Pubitemid 24299325)
6. Mecklenburg I, Stratakis DF, Huber RM, et al: Detection of melanoma antigen-A expression in sputum and bronchial lavage fluid of patients with lung cancer. Chest 125: 164S-166S, 2004. (Pubitemid 38648379)
7. Chaturvedi AK, Gaydos CA, Agreda P, et al: Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 19: 1498-1505, 2010.
8. Pastorino U: Lung cancer screening. Br J Cancer 102: 1681-1686, 2010.
9. Anglim PP, Alonzo TA and Laird-Offringa IA: DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer 7: 81, 2008.
10. Yasufuku K: Early diagnosis of lung cancer. Clin Chest Med 31: 39-47, 2010.
11. Sienel W, Varwerk C, Linder A, et al: Melanoma associated antigen (MAGE)-A3 expression in stages I and II non-small cell lung cancer: results of a multi-center study. Eur J Cardiothorac Surg 25: 131-134, 2004. (Pubitemid 38019071)
12. Atanackovic D, Altorki NK, Cao Y, et al: Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming. Proc Natl Acad Sci USA 105: 1650-1655, 2008. (Pubitemid 351346569)
13. + T cells in cancer patients and healthy individuals and their activation by protein vaccination. J Immunol 183: 4800-4808, 2009.
14. Risch A and Plass C: Lung cancer epigenetics and genetics. Int J Cancer 123: 1-7, 2008. (Pubitemid 351705185)
15. Kim H, Kim SJ, Lee SH, et al: Usefulness of melanoma antigen (MAGE) gene analysis in tissue samples from percutaneous needle aspiration biopsy of suspected lung cancer lesions. Lung Cancer 69: 284-288, 2010.
16. Zheng W, Blot WJ, Liao ML, et al: Lung cancer and prior tuberculosis infection in Shanghai. Br J Cancer 56: 501-504, 1987. (Pubitemid 17146360)
17. Kurasawa T: The coexistence of pulmonary tuberculosis and lung cancer. Nihon Rinsho 56: 3167-3170, 1998.
18. Olaussen KA, Soria JC, Park YW, et al: Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLC. Eur J Cancer 41: 2112-2119, 2005. (Pubitemid 41337953)
19. Kim YT, Lee SH, Sung SW, et al: Can aberrant promoter methylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection? Ann Thorac Surg 79: 1180-1188, 2005. (Pubitemid 40431836)
20. Kim DS, Cha SI, Lee JH, et al: Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population. Lung Cancer 58: 1-6, 2007.
21. Ulivi P, Zoli W, Calistri D, et al: p16INK4A and CDH13 methylation in tumor and serum of non-small cell lung cancer patients. J Cell Physiol 206: 611-615, 2006. (Pubitemid 43191035)
22. Liu Y, An Q, Li L, et al: Methylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications. Carcinogenesis 24: 1897-1901, 2003. (Pubitemid 38008529)
23. Hsu HS, Chen TP, Wen CK, et al: Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment. J Pathol 213: 412-419, 2007.
24. Yang B, O'Herrin SM, Wu J, et al: MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 67: 9954-9962, 2007. (Pubitemid 47621245)
25. Jeon CH, Shin IH, Park JB, et al: Prognostic significance of MAGE in peritoneal washes in gastric carcinoma patients without peritoneal metastasis: results of a 5-year follow-up study. J Clin Gastroenterol 44: 682-686, 2010.